// App-Quantinova.ai

: A single-centre, placebo-controlled, double-blinded, randomized, cross-over study of Iloprost in patients with Eisenmenger syndrome

Researchers

Presenter

  • Heba Nashat

Principal Investigators

  • Carl Harries

  • Lisa Parfitt

  • Emily Shaw

  • Aleksander Kempny

  • Laura C Price

  • Michael A Gatzoulis

  • Konstantinos Dimopoulos

  • Stephen J Wort

Medical Centers

  • Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Eisenmenger syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Iloprost

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Cross Over

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved